AutismFamilyOnline.com
Home | Discussion Forum | Tell a Friend | Text Size | Search | Member Area
 Join Us
Gain immediate access to all our articles, features, how-to's, downloads, discussion forum, archives plus lots more.  Click here for details.
 About this Site
About this Site
From the Publisher
Join Today
More About Us
Sample Articles
 Special Access
Webinar of the Month
Bonus Q &A Calls
Webinar Archives
GOLD Vault
 DEPARTMENTS
APPS, Tech & More ...
Article Library
Audio Library
Autism 101
Autism Family Video
Behavior
Best Practices
Communication
Community
Employment
Family Focus
Health
Healthy Eating
Holidays
In the News
Independence
Individual Needs
iPad, Tablets & More ...
iPads & Accessories
Marianne's BLOG
Medical
Military
Most Popular
Other Fun Stuff
Picture Library
Printables
Public Safety
Question Library
Recreation
Research & References
Resource Directory
Reviews
School
Sensory
Site Map
Social Skills
Spanish
Spiritual
Summer Fun
Surveys
Tip of the Week
Transition
Travel
Video Library
Visual Samples
Visual Strategies
Webinars
Subscribe to our RSS Feed
 RESOURCES
Article Index
Contact Us
FAQ
Help
Links
Tell a Friend
Text Size
Your Account
 PRODUCTS
Books
 Other
Media
Our Guarantee
Privacy Policy
Submissions
Terms of Use


This site powered by MemberGate


Parent Training Complements Medication for Treating Behavioral Problems in Children with Pervasive Developmental Disorders

 

Treatment that includes medication plus a structured training program for parents reduces serious behavioral problems in children with autism and related conditions, according to a study funded by the National Institute of Mental Health (NIMH). The study, which was part of the NIMH Research Units on Pediatric Psychopharmacology (RUPP) Autism Network, was published in the December 2009 issue of the Journal of the American Academy of Child and Adolescent Psychiatry.

Results from a previous RUPP study reported in 2002 showed that the antipsychotic medication risperidone (Risperdal) reduced such behavior problems as tantrums, aggression and self-injury in children with autism. However, most children's symptoms returned when the medication was discontinued. Although effective, risperidone is associated with adverse effects such as weight gain, which can lead to metabolic changes, obesity and related health problems.

"Medication alone has been shown to help with some symptoms of autism, but its potential is limited," said NIMH Director Thomas R. Insel. "This study shows promise of a more effective treatment protocol that could improve life for children with autism and their families."

In the study, the RUPP group tested the benefits of medication alone compared to medication plus a parent training program that actively involves parents in managing their children's severely disruptive and noncompliant behavior. Parents were taught to modify their children's behavior and learned to enhance their children's daily living skills.

The 24-week, three-site trial included 124 children ages 4 to 13 with pervasive developmental disorders (PDD) such as autism, Asperger's or related disorders accompanied by tantrums, aggression and self-injury. The children were randomized to a combination of risperidone and parent training, or to risperidone only. Parents in combination therapy received an average of 11 sessions of training over the course of the study.

Although both groups improved over the six-month trial, the group receiving combination therapy showed greater reduction in behavioral problems like irritability, tantrums and impulsiveness compared to the group receiving medication only. The combination therapy group also ended the trial taking an average dose of 1.98 milligrams (mg) per day of risperidone, compared to 2.26 mg/day in the medication-only group—a 14-percent lower dose. However, children in both groups gained weight, indicating "a need to learn more about the metabolic consequences of medications like risperidone," said the authors.

"The combination group was able to achieve its gains with a lower dose of medication. Plus, it appeared that the benefits of added behavioral treatment increased over time, a strong signal that actively including parents in the treatment of children with PDD could only benefit families, " said lead author Michael Aman, Ph.D., of the Ohio State University.

"Future studies will evaluate whether the benefits of parent training endure over a long period of time," concluded the authors. The investigators also plan to apply the parent training to younger children with PDD to prevent the evolution of serious behavioral problems. Future studies may also look for ways in which the parent training program can be used in schools and community clinics.

To read more.......

 

© AutismFamilyOnline.com 




Printer-Friendly Format
·  Lack of Eye Contact May Predict Level of Social Disability in Two-Year Olds with Autism
·  Considering Residential Living for Children with Autism
·  Registering Your Child with Autism with the Police Department
·  Sensory Integration for Children with Learning Disabilities - Introduction
·  CDC Staement on Autism Data